These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8302592)

  • 1. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
    Ciardiello F; Tortora G; Bianco C; Selvam MP; Basolo F; Fontanini G; Pacifico F; Normanno N; Brandt R; Persico MG
    Oncogene; 1994 Jan; 9(1):291-8. PubMed ID: 8302592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
    Normanno N; Bianco C; Damiano V; de Angelis E; Selvam MP; Grassi M; Magliulo G; Tortora G; Bianco AR; Mendelsohn J; Salomon DS; Ciardiello F
    Clin Cancer Res; 1996 Mar; 2(3):601-9. PubMed ID: 9816209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.
    Normanno N; De Luca A; Maiello MR; Bianco C; Mancino M; Strizzi L; Arra C; Ciardiello F; Agrawal S; Salomon DS
    Int J Oncol; 2004 Oct; 25(4):1013-20. PubMed ID: 15375551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line.
    Baldassarre G; Bianco C; Tortora G; Ruggiero A; Moasser M; Dmitrovsky E; Bianco AR; Ciardiello F
    Int J Cancer; 1996 May; 66(4):538-43. PubMed ID: 8635871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML
    J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
    Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
    Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.
    Laird AD; Brown PI; Fausto N
    Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of Cripto-1 expression by a hammerhead-shaped RNA molecule results from inhibition of translation rather than mRNA cleavage.
    Kintner RL; Hosick HL
    Biochem Biophys Res Commun; 1998 Apr; 245(3):774-9. PubMed ID: 9588190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
    Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells.
    Wechselberger C; Ebert AD; Bianco C; Khan NI; Sun Y; Wallace-Jones B; Montesano R; Salomon DS
    Exp Cell Res; 2001 May; 266(1):95-105. PubMed ID: 11339828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto: roles in mammary cell growth, survival, differentiation and transformation.
    Niemeyer CC; Persico MG; Adamson ED
    Cell Death Differ; 1998 May; 5(5):440-9. PubMed ID: 10200494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.
    Aharinejad S; Abraham D; Paulus P; Abri H; Hofmann M; Grossschmidt K; Schäfer R; Stanley ER; Hofbauer R
    Cancer Res; 2002 Sep; 62(18):5317-24. PubMed ID: 12235002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
    Normanno N; Tortora G; De Luca A; Pomatico G; Casamassimi A; Agrawal S; Mendelsohn J; Bianco AR; Ciardiello F
    Oncol Rep; 1999; 6(5):1105-9. PubMed ID: 10425310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.